Online pharmacy Ro has acquired Dadi, a sperm collection and testing startup, for approximately $100 million, say people with knowledge of the deal terms. The acquisition comes on the heels of a recent $150 million fundraising round from existing investors at a $7 billion valuation. It’s also happening during a transitional period for telehealth companies, which are having to figure out their main value proposition as the pandemic winds down and people are no longer confined to their homes.
Ro got its start prescribing medications that patients may have been too embarrassed to ask their physicians for, most notably generic Viagra. Fertility challenges can be similarly difficult to talk through with a provider, making them a natural extension of Ro’s core business. Prior to the Dadi acquisition, Ro purchased at-home fertility testing for women company Modern Fertility. Marco DeMeireles at the Chernin Group, an investor in both Dadi and Ro, introduced the two companies.
Dadi was…
Read More…
Source : fastcompany.com
Source link
